Bioseeker, March 2011
"AnalyticalTool - ColorectalCancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectalcancer R&D and business development
Bioseeker, March 2011, Pages: 1056
Cancer Drugs
6.8 Pathway Assessment of ColorectalCancer Drugs
6.8.1 Tools for Analysis of Cancer Pathways
6.8.2 Pathway Assessment
7 Emerging New Products to Established Ones: Drug Target
Bioseeker, July 2011, Pages: 3038
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Lung Cancer
The lung cancer report part comprises defined and up to date development
Bioseeker, March 2011, Pages: 2628
strategies, and assesses them in eight different compound strategies in colorectalcancer. This part is based on the following publication: A Decision Support Tool for Optimizing The ColorectalCancer Pipeline
Bioseeker, July 2011, Pages: 3292
strategies in colorectalcancer. This part is based on the following publication: A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market Part III: Lung
Bioseeker, March 2011, Pages: 2325
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Pancreatic Cancer
The pancreatic cancer report part comprises defined and up to date
Bioseeker, March 2011, Pages: 2553
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Prostate Cancer
The prostate cancer report part comprises defined and up to date
Bioseeker, July 2011, Pages: 2989
drug target strategies, and assesses them in eight different compound strategies in colorectalcancer.
This part is based on the following publication:
A Decision Support Tool for Optimizing
Bioseeker, July 2011, Pages: 3217
strategies, and assesses them in eight different compound strategies in colorectalcancer.
This part is based on the following publication:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline
Bioseeker, March 2011, Pages: 2579
different compound strategies in colorectalcancer. This part is based on the following publication: A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development
Bioseeker, March 2011, Pages: 2807
different compound strategies in colorectalcancer. This part is based on the following publication: A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development
Bioseeker, March 2011, Pages: 2504
drug target strategies, and assesses them in eight different compound strategies in colorectalcancer.
This part is based on the following publication:
A Decision Support Tool for Optimizing
Bioseeker, Sep 2011, Pages: 3659
is based on the following publication:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Cancer Vaccines
The cancer vaccine report part
Bioseeker, March 2011, Pages: 3157
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Cancer Vaccines
The cancer vaccine report part comprises defined and up to date
Bioseeker, Nov 2011, Pages: 2621
is based on the following publication:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Cancer Vaccines
The cancer vaccine report part
Bioseeker, Dec 2011, Pages: 3332
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date
Bioseeker, Jan 2012, Pages: 3419
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Angiogenesis
The angiogenesis affecting cancer drug report part comprises defined and up
Bioseeker, July 2011, Pages: 3821
:
A Decision Support Tool for Optimizing The ColorectalCancer Pipeline: From Research and Development to Market
Part II: Lung Cancer
The lung cancer report part comprises defined and up to date development
Bioseeker, Sep 2011, Pages: 4323
targets, organized into 205 drug target strategies, and assesses them in eight different compound strategies in colorectalcancer.
This part is based on the following publication:
A Decision Support Tool
Bioseeker, Dec 2011, Pages: 3996
targets, organized into 205 drug target strategies, and assesses them in eight different compound strategies in colorectalcancer.
This part is based on the following publication:
A Decision Support Tool